14:00 - 15:30      Session 1: Acute myeloid leukemia (AML)

Chairs: PK Gogoi (India), D Choudhary (India) & J Kotwal (India)

• Current strategies for treatment of childhood AML
  A Vora (United Kingdom)
• Panel discussion: Exploiting Venetoclax combinations induction in AML in India
  Moderator: V Mathews (India)
  Panelists: J Jomel (Philippines), S Pramanik (India), U Nath (India), P Samal (India) & N Agrawal (India)

15:30 - 17:00      Session 2: Chronic myeloid leukemia (CML)

Chairs: R Kar (India), AK Tripathi (India) & S Chandra (India)

• What can we learn from single cell studies in CML
  T Ong Sin (Singapore)
• Drug profiling for CML blast crisis
  S Mustjoki (Finland)
• Case based discussion: Beyond 2nd line treatment in CML
  H Khurana (India)
• Case based discussion: Eligibility and Success of TFR in LMIC
  R Kapoor (India)

17:00 - 17:15      Coffee break

17:15 - 18:45      Session 3: Thrombosis & hemostasis

Chairs: S Nair (India), N Gupta (India) & P Rojnuckarin (Thailand)

• Thrombosis & hemostasis update
  R Lassila (Finland)
• Platelets in ITP: Victims in charge of their own fate
  JW Semple (Sweden)
• Case based Panel discussion: Alternatives to SHL products in India- (EHL and Non factor therapies)
  Moderator: J John (India)
  Panelists: P Chakrabarti (India), N Sidharthan (India), J Bhattacharya (India), S Verma (India) & S Attri (India)
                                                                                    

18:45 - 19:45      Inauguration ceremony

07:30 - 08:30      Meet the Professors (Breakfast)

• A Vora (United Kingdom)
• S Mustjoki (Finland)
• R Lassila (Finland)

08:30 - 09:00      Bumper quiz

09:00 - 10:30      Session 4: Stem cell transplant and gene therapy           

Chairs: D Bhurani (India) & S Hongeng (Thailand)

• Current results of HSCT in acute lymphoblastic leukemia
  JH Dalle (France)
• Treatment options in transplant eligible MM patient or Is ASCT still a standard of care in MM?
  T Facon (France)
• Case based Panel discussion: Steroid refractory GvHD (acute and chronic)
• Moderators: P Mishra (India)
  Panelists: D Lad (India), R Sahoo (India), P Singh (India), A Chakrapani (Infia) & M Kumar (India)

10:30 - 12:00      Session 5: Myelodysplastic syndromes (MDS) & Myeloproliferative neoplasms (MPN)

Chairs: HP Pati (India), S Das (India), V Tilak (India) & N Ranasinghe (Sri Lanka)

• WHO vs. ICC Classification for MDS
  M Fontenay (France)
• Management of MDS
  Uwe Platzbecker (Germany)
• Case based Panel discussion: Managing primary MF- JAK2 inhibition and beyond
  Moderators: R Naithani (India)
  Panelists: K Mishra (India), T Dolai (India), R Kumar (India), A Jain (India) & N Gupta (India)

12:00 - 13:00      Session: Aplastic anemia / Bone marrow failure

Chair: PK Sasidharan (India)

• Alternative donor transplant in immune aplastic anemia
  JH Dalle (France)
• New insights in Gaucher Diseases
  MP Giraldo (Spain)

13:00 - 14:00      Lunch

14:00 - 15:30      Session 6: Laboratory hematology

Chairs: E Macintyre (France), S Khodaji (India) & V Iyer (India)

• Current and future clinical applications of whole genome sequencing in global precision hematology
  Anna Schuh (United Kingdom)
• EuroMRD: MRD assessment in pediatric Ph+ ALL reveals distinct biological subtypes with clinical consequences
  Jan Zuna (Czechia)
• Digital morphology in hematology diagnosis and education
  Gina Zini (Italy)              

15:30 - 17:00      Session 7: Acute Lymphoblastic Leukemia

Chairs: R Foà (Italy), K Mishra (India) & S Bakhshi (India)

• Treatment de-escalation in childhood ALL
  A Vora (United Kingdom)
• Adult ALL
  R Foà (Italy)
• The evolving place of diagnostics and MRD in T-ALL/T-LBL management
  E Macintyre (France)

17:00 - 17:30      Coffee break + poster walk

17:30 - 19:00      Session 8: Asian Joint Symposium

Chairs: E Macintyre (France) & M Mahapatra (India)

• India: Status of Cost-effective Utility of Molecular Diagnostics for Onco-hematology in India
  R Das (India)
• Thailand: NGS for myeloid and lymphoid malignancy in Thailand
  C Polprasert (Thailand)
• Philippines: Experience in Benchmarking of our Pediatric Hematology Fellowship Training
  E Rodriguez (Philippines)
• Access to Molecular innovative diagnostics for Onco-Hematology in Malaysia
  S Yeggapan (Malaysia)
• Molecular diagnostic services for Onco-haematology in Sri Lanka
  H Goonasekera (Sri Lanka)

19:00 - 20:00      Cultural program             

07:30 - 08:30      Meet the Professors (Breakfast)

• R Foà (Italy)
• U Platzbecker (Germany)
• E Macintyre (France)

08:30 - 09:00      Hematology quiz                          

09:00 - 10:30      Session 9: Benign hematology

Chairs: K Ghosh (India), S Behera (India) & JM Khunger (India)

• Hemochromatosis
  D Girelli (Italy)
• How to manage severe iron deficiency anemia in the emergency room minimizing RBC transfusions
  I Beverina (Italy)
• Case based Panel discussion: Complications related to thalassemia / SCD / Hemoglobinopathy management- challenges and policy implementation
  Moderator: M Bhattacharya (India)
  Panelists: RK Jena (India), G Singh (India), AK Ganju (India) & A Garg (India)

10:30 - 11:30      Session 11: Lymphoma - Part 1

Chairs: M Dreyling (Germany), A Gogia (india) & A Sharma (India)

• Reclassification of lymphomas - How, why and what are the clinical implications?
  Andrew Davies (United Kingdom)
• Overview of mantle cell lymphoma
  Martin Dreyling (Germany)

11:30 - 12:00      Poster walk

12:00 - 13:00      Session 12: Lymphoma - Part 2

Chairs: S Varma (India) & T Chatterjee (India)

• Evidence based patient-reported outcomes measures in lymphoma clinical trials
  EN Oliva (Italy)
• Panel discussion: Relapsed Hodgkin Lymphoma in India - What can we do in LMIC
  Moderator: G Prakash (India)
  Panelists: R Ahmad (India), S Ranjan (India), J Singh (India), S Sharma (India) & J Igama (Philippines)

13:00 - 14:00      Lunch

14:00 - 15:30      Session 13: Myeloma

Chairs: D Coriu (Romania) & L Kumar (India)

• What is the optimal duration of therapy in multiple myeloma?
  T Facon (France)
• Updates in using novel therapies and immunotherapies for multiple myeloma
  D Coriu (Romania)
• Panel discussion: Juggling the therapies in relapsed Multiple myeloma in India
  Moderator: P Malhotra (India)
  Panelists: AK Singh (India), A Chopra (India), E Kaul (India), R De (India) & A Abraham (India)

15:30 - 16:00      Valedictory function and prize distribution